Swiss cantons offer fertile investment ground
This article was originally published in Clinica
Switzerland's favourable tax laws for foreign corporations were the theme of a conference earlier this month at the Swiss Embassy in London. Representatives from Swiss cantons were on hand to contrast the Swiss situation with the rest of Europe in a bid to increase the number of companies in the medical device and other industries that have already decided to relocate to the country.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.